BlackRock Japan’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$22K Buy
10,556
+8,895
+536% +$17.9K ﹤0.01% 1108
2016
Q3
$4K Hold
1,661
– – ﹤0.01% 1272
2016
Q2
$5K Buy
1,661
+1,187
+250% +$7.44K ﹤0.01% 1349
2016
Q1
$4K Hold
474
– – ﹤0.01% 1383
2015
Q4
$6K Sell
474
-36
-7% -$443 ﹤0.01% 1318
2015
Q3
$5K Sell
510
-79
-13% -$1.16K ﹤0.01% 1217
2015
Q2
$8K Buy
+589
New +$6.47K ﹤0.01% 1286
2014
Q2
– Sell
-539
Closed -$8K – 1422
2014
Q1
$8K Buy
+539
New +$8.5K ﹤0.01% 1356

Other funds holding IMGN

BlackRock Japan's IMGN Position: Q4 2016 in Review

BlackRock Japan increased its Immunogen Inc (IMGN) stake by 536% in Q4 2016, buying an estimated $17.9K and bringing the position to 10,556 shares worth $22K. The position accounts for ﹤0.01% of the portfolio, ranked #1108.

BlackRock Japan first reported a position in IMGN in Q1 2014 and has held it in 8 quarters since. 156 funds tracked by Wall St. Rank hold IMGN as of Q4 2016.

  • BlackRock Japan held 10,556 shares of Immunogen Inc worth $22K as of Q4 2016.
  • BlackRock Japan bought 8,895 Immunogen Inc shares in Q4 2016, an estimated $17.9K.
  • Immunogen Inc made up ﹤0.01% of BlackRock Japan's portfolio in Q4 2016, its #1108 holding.
  • BlackRock Japan first reported a position in Immunogen Inc in Q1 2014 and has held it in 8 quarters since.
  • 156 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2016.

Based on BlackRock Japan's 13F filing for Q4 2016, filed 10 Feb 2017.